Figure 5. Nomogram creation and validation. (A) A nomogram combining clinicopathological variables and risk score predicts 1-year, 3-year, and 5-year OS rate of BLCA patients. (B–D) The calibration curves for the OS nomogram model in BLCA at 1-year, 3-year, and 5-year. Abbreviations: OS: overall survival; BLCA: Bladder urothelial carcinoma; N: lymph node; M: metastasis.